Related Experiment Videos
Visual recognition memory in drug-exposed infants
1Department of Pediatrics, University of California, Davis Medical Center 95817.
Insights
Prenatal stimulant drug exposure, including cocaine and amphetamines, is linked to lower visual recognition memory in infants. This early cognitive deficit may predict later neurological issues, detectable before school age.
Area of Science:
- Neuroscience
- Developmental Psychology
- Pediatrics
Background:
- Visual recognition memory in high-risk infants predicts later cognitive deficits.
- Prenatal exposure to illicit stimulant drugs is a concern for infant neurodevelopment.
Purpose of the Study:
- To evaluate cognitive function in infants exposed prenatally to illicit stimulant drugs using the Fagan Test of Infant Intelligence (FTII).
- To compare cognitive outcomes between drug-exposed and non-exposed infants.
Main Methods:
- Utilized the Fagan Test of Infant Intelligence (FTII), a standardized visual recognition memory test.
- Compared 36 infants with prenatal exposure to cocaine/amphetamines with 26 non-exposed, matched controls.
- Assessed behaviors related to attention, distractibility, and activity levels.
Main Results:
- Infants with prenatal stimulant exposure demonstrated significantly lower average FTII scores.
- A higher percentage of drug-exposed infants tested at risk for cognitive deficits (p < .01).
- Group differences were observed in attention, distractibility, and activity levels.
Conclusions:
- Prenatal stimulant drug exposure is associated with early visual recognition memory deficits in infants.
- These findings suggest potential subtle neurological abnormalities in exposed infants, identifiable early in life.
- Early cognitive assessment may aid in identifying infants at risk for developmental issues.
Abstract:
Visual recognition memory testing in high-risk infants has been shown to have significant predictive ability for later cognitive deficits. This study evaluated cognition in infants exposed prenatally to illicit stimulant drugs compared with nonexposed controls with a standardized test of visual recognition, the Fagan Test of Infant Intelligence (FTII). Thirty-six healthy, full-term infants with prenatal exposure to cocaine and/or amphetamines and 26 infants with no drug exposures, matched for race and socioeconomic status, were tested. Average FTII scores were significantly lower and the percentage testing at risk significantly higher in the drug-exposed group (p less than .01). Differences between groups were also noted in behaviors dealing with attention, distractibility, and activity level. These data support recent evidence from longitudinal studies showing that infants exposed to drugs prenatally may be at risk for later subtle neurological abnormalities and suggest these difficulties may be identifiable long before the children reach school age.